
欧洲冷冻组织样本市场预测至 2028 年 - COVID-19 影响和按产品类型(冷冻正常组织样本、冷冻肿瘤组织样本和冷冻患病组织样本)、应用(疾病诊断和治疗、癌症和其他疾病研究、和形态分析)和最终用户(学术和研究机构、医院和诊所、诊断中心等)
No. of Pages: 117 | Report Code: BMIRE00025196 | Category: Life Sciences
No. of Pages: 117 | Report Code: BMIRE00025196 | Category: Life Sciences
根据英国癌症研究中心2020年公布的数据,英国每年约有16万人死于癌症。此外,根据 Globocan 报告,2020 年,女性乳腺癌病例数超过肺癌,成为诊断最多的癌症,估计新增病例 230 万例(11.7%)。其次是肺癌、结直肠癌、前列腺癌和胃癌,检出率分别为11.4%、10.0%、7.3%和5.6%。转型国家的总体发病率比转型国家高 2 至 3 倍。然而,转型期女性乳腺癌和宫颈癌的死亡率远高于转型期国家。如此高的癌症患病率正在推动对冷冻组织样本进行研究和研究的需求。使用冷冻肿瘤组织样本进行的研究确立了这种慢性疾病的几种诊断和治疗范围。
与新的功能和技术,供应商可以吸引新客户并扩大他们在新兴市场的足迹。这一因素可能会在预测期内推动欧洲冷冻组织样本市场实现显着的复合年增长率。
欧洲冷冻组织样本市场是根据产品类型、应用、最终用户和国家/地区进行细分。根据产品,市场分为冷冻正常组织样本、冷冻肿瘤组织样本和冷冻患病组织样本。 2021年,冷冻组织肿瘤样本细分市场占据最大份额。根据应用,欧洲冷冻组织样本市场细分为疾病诊断和治疗、癌症和其他疾病研究以及形态分析。 2021年,癌症和其他疾病研究领域占据了最大的市场份额。按最终用户划分,欧洲冷冻组织样本市场分为学术和研究机构、医院和诊所、诊断中心等。 2021年,学术和研究机构细分市场占有最大的市场份额。根据国家/地区,欧洲冷冻组织样本市场分为法国、德国、意大利、英国、俄罗斯和欧洲其他地区。
p>
AMS 生物技术有限公司;奥杜邦生物科学公司;海湾生物科学有限责任公司;生物链研究所有限公司;奥瑞基因科技有限公司; ProteoGenex 公司; REPROCELL 公司;和 ZenBio, Inc. 是欧洲冷冻组织样本市场的领先公司之一。
Strategic insights for Europe Frozen Tissues Samples involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 13.45 Million |
Market Size by 2028 | US$ 30.32 Million |
Global CAGR (2021 - 2028) | 12.3% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 产品类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Frozen Tissues Samples refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Frozen Tissues Samples Market is valued at US$ 13.45 Million in 2021, it is projected to reach US$ 30.32 Million by 2028.
As per our report Europe Frozen Tissues Samples Market, the market size is valued at US$ 13.45 Million in 2021, projecting it to reach US$ 30.32 Million by 2028. This translates to a CAGR of approximately 12.3% during the forecast period.
The Europe Frozen Tissues Samples Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Frozen Tissues Samples Market report:
The Europe Frozen Tissues Samples Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Frozen Tissues Samples Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Frozen Tissues Samples Market value chain can benefit from the information contained in a comprehensive market report.